Results 301 to 310 of about 297,195 (347)
Some of the next articles are maybe not open access.
Current Opinion in Gastroenterology, 2003
This review describes significant basic science and clinical advances in the field of pancreatic neoplasms.Some of the genetic and molecular bases for the aggressive behavior of pancreatic cancer have been uncovered, and new targets for therapy have been identified.
John P, Duffy, Howard A, Reber
openaire +2 more sources
This review describes significant basic science and clinical advances in the field of pancreatic neoplasms.Some of the genetic and molecular bases for the aggressive behavior of pancreatic cancer have been uncovered, and new targets for therapy have been identified.
John P, Duffy, Howard A, Reber
openaire +2 more sources
Current Opinion in Gastroenterology, 2004
This review includes a summary of articles that have affected the study and treatment of pancreatic neoplasms over the past year.Over the past year, there have been several reports of new animal models of pancreatic cancer that recapitulate the human disease and hold promise for preclinical studies.
Oscar J, Hines, Howard A, Reber
openaire +2 more sources
This review includes a summary of articles that have affected the study and treatment of pancreatic neoplasms over the past year.Over the past year, there have been several reports of new animal models of pancreatic cancer that recapitulate the human disease and hold promise for preclinical studies.
Oscar J, Hines, Howard A, Reber
openaire +2 more sources
Pancreatic Neoplasms and Autophagy
Current Drug Targets, 2018Pancreatic cancer is predicted to be the second deadliest malignancy (a median survival of 4-6 months and a 5-year survival of less than 5%) in the USA by 2020. Although current medical detection technologies have dramatically improved the survival rate for patients with other gastrointestinal malignancies, the dismal clinical outcome remains somewhat ...
Linzi A, Barton, Jun, Ren
openaire +2 more sources
Pancreatic Neuroendocrine Neoplasms
Surgical Pathology Clinics, 2014Pancreatic neuroendocrine neoplasms (Pan-NENs) are rare but clinically important lesions. Pan-NENs are known for and often categorized by their capacity to produce clinical syndromes mediated by the production of hormones. Despite sometimes presenting dramatically from excessive hormone production, not all Pan-NENs produce functional hormone, and they ...
J N, Rosenbaum, Ricardo Vincent, Lloyd
openaire +2 more sources
Imaging of Pancreatic Neoplasms
Surgical Oncology Clinics of North America, 2014Ductal adenocarcinoma accounts for 85% to 90% of all solid pancreatic neoplasms, is increasing in incidence, and is the fourth leading cause of cancer-related deaths. There are currently no screening tests available for the detection of ductal adenocarcinoma. The only chance for cure in pancreatic adenocarcinoma is surgery.
Aparna, Balachandran +3 more
openaire +2 more sources
Radiologic Clinics of North America, 1989
Cystic neoplasms are an uncommon group among pancreatic tumors. Because of advances in noninvasive diagnostic procedures, these lesions are more frequently detected and surgically treated. New pathological entities have been recently described with their own prognosis. 1.
D, Mathieu +7 more
openaire +2 more sources
Cystic neoplasms are an uncommon group among pancreatic tumors. Because of advances in noninvasive diagnostic procedures, these lesions are more frequently detected and surgically treated. New pathological entities have been recently described with their own prognosis. 1.
D, Mathieu +7 more
openaire +2 more sources
Molecular Genetics of Pancreatic Neoplasms
Surgical Pathology Clinics, 2016Pancreatic neoplasms have a wide range of histologic types with distinct clinical outcomes. Recent advances in high-throughput sequencing technologies have greatly deepened our understanding of pancreatic neoplasms. Now, the exomes of major histologic types of pancreatic neoplasms have been sequenced, and their genetic landscapes have been revealed ...
Waki, Hosoda, Laura D, Wood
openaire +2 more sources
SCHWANNOMA: A RARE PANCREATIC NEOPLASM
Journal of Investigative Medicine, 2005Background Pancreatic schwannomas are rare neoplasms, which typically affect the adult population. The size of these tumors is highly variable. Since two thirds of these tumors are partially cystic, they grossly mimic cystadenomas and cystadenocarcinomas of the pancreas. The most common presenting symptom is abdominal pain.
T.D. Bui +3 more
openaire +1 more source
Nonoperative Ablation of Pancreatic Neoplasms
Surgical Clinics of North America, 2018Pancreatic cancer is a poor prognostic tumor and about 20% of patients are eligible for surgical resection at the time of diagnosis. Recently, minimally invasive procedures have provided promising results as a therapeutic option for locally advanced unresectable pancreatic cancer.
Marrocchio C +3 more
openaire +2 more sources
Molecular Characterization of Pancreatic Neoplasms
Advances in Anatomic Pathology, 2008Molecular analyses of neoplasms of the pancreas, coupled with careful histopathologic examination has helped refine the classification of pancreatic neoplasia. A number of molecularly and histologically distinct subtypes of pancreatic neoplasms have been identified and, importantly, many of these subtypes have important clinical implications.
Chanjuan, Shi +2 more
openaire +2 more sources